---
keywords:
  - Medial Temporal Lobe
  - Magnetic Resonance Imaging
  - Hippocampal Subfields
  - Neural Network
  - Alzheimer's Disease
category: cs.CV
publish_date: 2025-09-25
arxiv_id: 2504.18442
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-26T09:29:54.748184",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Medial Temporal Lobe",
    "Magnetic Resonance Imaging",
    "Hippocampal Subfields",
    "Neural Network",
    "Alzheimer's Disease"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Medial Temporal Lobe": 0.78,
    "Magnetic Resonance Imaging": 0.8,
    "Hippocampal Subfields": 0.77,
    "Neural Network": 0.75,
    "Alzheimer's Disease": 0.85
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Medial Temporal Lobe",
        "canonical": "Medial Temporal Lobe",
        "aliases": [
          "MTL"
        ],
        "category": "unique_technical",
        "rationale": "The Medial Temporal Lobe is a critical region for understanding neurodegenerative diseases, offering specific insights into Alzheimer's disease progression.",
        "novelty_score": 0.65,
        "connectivity_score": 0.7,
        "specificity_score": 0.85,
        "link_intent_score": 0.78
      },
      {
        "surface": "MRI",
        "canonical": "Magnetic Resonance Imaging",
        "aliases": [
          "MRI"
        ],
        "category": "broad_technical",
        "rationale": "MRI is a fundamental imaging technique used extensively in medical research and practice, providing a strong link to a wide range of studies.",
        "novelty_score": 0.3,
        "connectivity_score": 0.9,
        "specificity_score": 0.6,
        "link_intent_score": 0.8
      },
      {
        "surface": "Hippocampal Subfields",
        "canonical": "Hippocampal Subfields",
        "aliases": [],
        "category": "specific_connectable",
        "rationale": "Hippocampal subfields are crucial for detailed brain segmentation studies, particularly in Alzheimer's research.",
        "novelty_score": 0.6,
        "connectivity_score": 0.75,
        "specificity_score": 0.8,
        "link_intent_score": 0.77
      },
      {
        "surface": "nnUNet",
        "canonical": "Neural Network",
        "aliases": [
          "nnUNet"
        ],
        "category": "broad_technical",
        "rationale": "nnUNet is a specific neural network model used for segmentation tasks, linking to broader neural network applications.",
        "novelty_score": 0.55,
        "connectivity_score": 0.85,
        "specificity_score": 0.7,
        "link_intent_score": 0.75
      },
      {
        "surface": "Alzheimer's Disease",
        "canonical": "Alzheimer's Disease",
        "aliases": [
          "AD"
        ],
        "category": "specific_connectable",
        "rationale": "Alzheimer's Disease is a major focus of neurodegenerative research, providing a direct link to related studies and findings.",
        "novelty_score": 0.4,
        "connectivity_score": 0.88,
        "specificity_score": 0.9,
        "link_intent_score": 0.85
      }
    ],
    "ban_list_suggestions": [
      "method",
      "experiment",
      "performance"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Medial Temporal Lobe",
      "resolved_canonical": "Medial Temporal Lobe",
      "decision": "linked",
      "scores": {
        "novelty": 0.65,
        "connectivity": 0.7,
        "specificity": 0.85,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "MRI",
      "resolved_canonical": "Magnetic Resonance Imaging",
      "decision": "linked",
      "scores": {
        "novelty": 0.3,
        "connectivity": 0.9,
        "specificity": 0.6,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "Hippocampal Subfields",
      "resolved_canonical": "Hippocampal Subfields",
      "decision": "linked",
      "scores": {
        "novelty": 0.6,
        "connectivity": 0.75,
        "specificity": 0.8,
        "link_intent": 0.77
      }
    },
    {
      "candidate_surface": "nnUNet",
      "resolved_canonical": "Neural Network",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.85,
        "specificity": 0.7,
        "link_intent": 0.75
      }
    },
    {
      "candidate_surface": "Alzheimer's Disease",
      "resolved_canonical": "Alzheimer's Disease",
      "decision": "linked",
      "scores": {
        "novelty": 0.4,
        "connectivity": 0.88,
        "specificity": 0.9,
        "link_intent": 0.85
      }
    }
  ]
}
-->

# Imaging Biomarkers for Neurodegenerative Diseases from Detailed Segmentation of Medial Temporal Lobe Subregions on in vivo Brain MRI Using Upsampling Strategy Guided by High-resolution ex vivo MRI

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250925|20250925]] [[categories/cs.CV|cs.CV]]
**PDF**: [Download](https://arxiv.org/pdf/2504.18442.pdf)
**Category**: cs.CV
**Published**: 2025-09-25
**ArXiv ID**: [2504.18442](https://arxiv.org/abs/2504.18442)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-24/Multi-Scale Graph Theoretical Analysis of Resting-State fMRI for Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls_20250924|Multi-Scale Graph Theoretical Analysis of Resting-State fMRI for Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls]] (87.3% similar)
- [[2025-09-18/Brain age identification from diffusion MRI synergistically predicts neurodegenerative disease_20250918|Brain age identification from diffusion MRI synergistically predicts neurodegenerative disease]] (83.8% similar)
- [[2025-09-23/Improved mmFormer for Liver Fibrosis Staging via Missing-Modality Compensation_20250923|Improved mmFormer for Liver Fibrosis Staging via Missing-Modality Compensation]] (83.6% similar)
- [[2025-09-22/SLaM-DiMM_ Shared Latent Modeling for Diffusion Based Missing Modality Synthesis in MRI_20250922|SLaM-DiMM: Shared Latent Modeling for Diffusion Based Missing Modality Synthesis in MRI]] (83.3% similar)
- [[2025-09-24/MOIS-SAM2_ Exemplar-based Segment Anything Model 2 for multilesion interactive segmentation of neurobromas in whole-body MRI_20250924|MOIS-SAM2: Exemplar-based Segment Anything Model 2 for multilesion interactive segmentation of neurobromas in whole-body MRI]] (82.8% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Magnetic Resonance Imaging|Magnetic Resonance Imaging]], [[keywords/Neural Network|Neural Network]]
**ğŸ”— Specific Connectable**: [[keywords/Hippocampal Subfields|Hippocampal Subfields]], [[keywords/Alzheimer's Disease|Alzheimer's Disease]]
**âš¡ Unique Technical**: [[keywords/Medial Temporal Lobe|Medial Temporal Lobe]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2504.18442v2 Announce Type: replace-cross 
Abstract: The medial temporal lobe (MTL) is a region impacted extensively and non-uniformly in early stages of Alzheimer's disease (AD). Regional MTL morphometric measures extracted from magnetic resonance imaging (MRI) are supportive features for the diagnosis of AD and related disorders (ADRD). Different MRI modalities have distinct advantages for MTL morphometry. Anisotropic T2-weighted (T2w) MRI is preferred for hippocampal subfields due to its higher contrast between hippocampal layers. Isotropic T1-weighted (T1w) MRI is beneficial for thickness calculation of extra-hippocampal subregions due to its stable image quality and isotropic resolution. We propose a multi-modality MTL segmentation algorithm that bridges the T1w and T2w modalities by bringing both to a nearly isotropic voxel space. Guided by high-resolution ex vivo 9.4T MRI, an upsampling model was designed for the ground truth segmentations. Combined with non-local means upsampling, this model was used to construct a nearly iso-tropic T1w and T2w MTL subregion segmentation training set, which was used to train a nnUNet model. Morphometric biomarkers extracted by this model were compared to those extracted using conventional models operating in anisotropic spaces on downstream tasks. Biomarkers extracted using the proposed model had greater ability to discriminate between individuals with mild cognitive impairment and cognitively unimpaired; and had great-er longitudinal stability. These findings suggest that the biomarkers derived from T1w and T2w MRI unsampled to nearly isotropic resolution have sig-nificant potential for improving disease diagnosis and monitoring disease progression in ADRD.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì•Œì¸ í•˜ì´ë¨¸ë³‘(AD)ì˜ ì´ˆê¸° ë‹¨ê³„ì—ì„œ ë¹„ê· ì¼í•˜ê²Œ ì˜í–¥ì„ ë°›ëŠ” ë‚´ì¸¡ ì¸¡ë‘ì—½(MTL)ì˜ í˜•íƒœ ì¸¡ì •ì„ ìœ„í•œ ìƒˆë¡œìš´ ë‹¤ì¤‘ ëª¨ë‹¬ë¦¬í‹° MTL ë¶„í•  ì•Œê³ ë¦¬ì¦˜ì„ ì œì•ˆí•©ë‹ˆë‹¤. T2 ê°€ì¤‘ MRIëŠ” í•´ë§ˆ í•˜ìœ„ í•„ë“œì˜ ë†’ì€ ëŒ€ë¹„ë¥¼ ì œê³µí•˜ê³ , T1 ê°€ì¤‘ MRIëŠ” ì•ˆì •ì ì¸ ì´ë¯¸ì§€ í’ˆì§ˆë¡œ í•´ë§ˆ ì™¸ë¶€ í•˜ìœ„ ì˜ì—­ì˜ ë‘ê»˜ ê³„ì‚°ì— ìœ ë¦¬í•©ë‹ˆë‹¤. ì œì•ˆëœ ì•Œê³ ë¦¬ì¦˜ì€ ë‘ ëª¨ë‹¬ë¦¬í‹°ë¥¼ ê±°ì˜ ë“±ë°©ì„±ì˜ ë³µì…€ ê³µê°„ìœ¼ë¡œ ë³€í™˜í•˜ì—¬ í†µí•©í•©ë‹ˆë‹¤. ê³ í•´ìƒë„ ex vivo 9.4T MRIë¥¼ ê¸°ë°˜ìœ¼ë¡œ ì—…ìƒ˜í”Œë§ ëª¨ë¸ì„ ì„¤ê³„í•˜ì—¬ nnUNet ëª¨ë¸ì„ í›ˆë ¨ì‹œì¼°ìŠµë‹ˆë‹¤. ì´ ëª¨ë¸ë¡œ ì¶”ì¶œí•œ í˜•íƒœê³„ì¸¡ ë°”ì´ì˜¤ë§ˆì»¤ëŠ” ê¸°ì¡´ ëª¨ë¸ë³´ë‹¤ ê²½ë„ ì¸ì§€ ì¥ì• ì™€ ì¸ì§€ì ìœ¼ë¡œ ê±´ê°•í•œ ê°œì¸ì„ ë” ì˜ êµ¬ë³„í•˜ê³ , ì¥ê¸°ì ì¸ ì•ˆì •ì„±ì´ ë›°ì–´ë‚¬ìŠµë‹ˆë‹¤. ì´ëŠ” ì œì•ˆëœ ëª¨ë¸ì´ AD ë° ê´€ë ¨ ì§ˆí™˜ì˜ ì§„ë‹¨ê³¼ ì§„í–‰ ëª¨ë‹ˆí„°ë§ì— ìœ ìš©í•  ê°€ëŠ¥ì„±ì„ ì‹œì‚¬í•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ë‚´ì¸¡ ì¸¡ë‘ì—½(MTL)ì€ ì•Œì¸ í•˜ì´ë¨¸ë³‘(AD) ì´ˆê¸° ë‹¨ê³„ì—ì„œ ë¹„ê· ì¼í•˜ê²Œ ì˜í–¥ì„ ë°›ëŠ” ì˜ì—­ì´ë‹¤.
- 2. MTLì˜ í˜•íƒœ ê³„ì¸¡ì€ MRIë¥¼ í†µí•´ AD ë° ê´€ë ¨ ì§ˆí™˜ì˜ ì§„ë‹¨ì„ ì§€ì›í•˜ëŠ” ì¤‘ìš”í•œ íŠ¹ì§•ì´ë‹¤.
- 3. T2 ê°€ì¤‘ MRIëŠ” í•´ë§ˆ í•˜ìœ„ í•„ë“œì˜ ë†’ì€ ëŒ€ì¡°ë„ë¡œ ì¸í•´ ì„ í˜¸ë˜ë©°, T1 ê°€ì¤‘ MRIëŠ” ì•ˆì •ì ì¸ ì´ë¯¸ì§€ í’ˆì§ˆë¡œ ì¸í•´ í•´ë§ˆ ì™¸ í•˜ìœ„ ì˜ì—­ ë‘ê»˜ ê³„ì‚°ì— ìœ ë¦¬í•˜ë‹¤.
- 4. ì œì•ˆëœ ë‹¤ì¤‘ ëª¨ë‹¬ë¦¬í‹° MTL ë¶„í•  ì•Œê³ ë¦¬ì¦˜ì€ T1wì™€ T2w ëª¨ë‹¬ë¦¬í‹°ë¥¼ ê±°ì˜ ë“±ë°©ì„±ì˜ ë³µì…€ ê³µê°„ìœ¼ë¡œ ë³€í™˜í•˜ì—¬ ì—°ê²°í•œë‹¤.
- 5. ì œì•ˆëœ ëª¨ë¸ë¡œ ì¶”ì¶œí•œ í˜•íƒœ ê³„ì¸¡ ë°”ì´ì˜¤ë§ˆì»¤ëŠ” ê²½ë„ ì¸ì§€ ì¥ì• ì™€ ì¸ì§€ì ìœ¼ë¡œ ì†ìƒë˜ì§€ ì•Šì€ ê°œì¸ì„ êµ¬ë³„í•˜ëŠ” ë° ë” ë›°ì–´ë‚œ ëŠ¥ë ¥ì„ ë³´ì˜€ë‹¤.


---

*Generated on 2025-09-26 09:29:54*